News

Tavexia Lifecare Limited, formerly known as Sattva Sukun Lifecare Limited, informed the BSE Limited that it is submitting a certificate under Regulation 74(5) of the Securities and Exchange Board of India (Depositories and participants) Regulations, 2018, received from Niche Technologies Pvt. Ltd., the company’s Registrar and Share Transfer Agent, for the quarter ended September 30, 2026.

Tavexia Lifecare Limited, formerly Sattva Sukun Lifecare Limited, informed the BSE Limited that the trading window for dealing in shares of the company will be closed for all directors, promoters, designated persons, and their immediate relatives, effective October 1, 2026, until 48 hours after the announcement of unaudited financial results for the quarter and half year ended September 30, 2026.

Tavexia Lifecare Limited, formerly Sattva Sukun Lifecare Limited, has informed the BSE Ltd. that its book closure will be from September 24, 2026, to September 30, 2026, both dates inclusive, for the purpose of the 46th Annual General Meeting.

Tavexia Lifecare Limited, formerly Sattva Sukun Lifecare, announced several key decisions following a board meeting held September 7, 2026. The company authorized the exploration of acquiring shares of Meyonex Pharmaceuticals Limited, a pharmaceutical company with a registered address in Palghar, Maharashtra, and an authorized capital of Rs 20,00,00,000. Additionally, the board accepted the resignation of M/s. SSRV and Associates as Statutory Auditors, effective immediately, and appointed M/s DEVAM & Associates LLP to the role, pending shareholder approval at the next Annual General Meeting. Mrs. Khushboo Vasudev was also re-appointed as an Independent Director for a second five-year term, also subject to shareholder approval. The Managing Director or Company Secretary will handle the AGM notice and e-voting process, in compliance with SEBI regulations.

Tavexia Lifecare Limited, formerly Sattva Sukun Lifecare Limited, will hold a board meeting on Friday, September 4, 2026, to consider the re-appointment of Mrs. Khushboo Vasudev as an Independent Director for a second term of five years from December 31, 2026, subject to shareholder approval, and to approve a proposal for Material Related Party Transactions under section 188 of the Companies Act 2013, also pending shareholder approval.